Monica Gandhi, MD, MPH

Phone: 415-502-6285
UCSF Box: 1352
Email: [email protected]
UCSF Profile

Project Sponsor Location(s) Topics Start End
Point-of-care Urine Monitoring of Adherence (PUMA): Testing a Real-Time Urine Assay of Tenofovir in PrEP NIH National Institute of Allergy and Infectious Disease Kenya HIV/AIDS, Women's Health, Treatment Adherence
Project Sponsor Location(s) Topics Start End
Determination of Reyataz (Atazanavir Sulfate) Levels in Hair: A New Assay and Possible Predictor for Long-Term Virologic Outcome Bristol-Myers Squibb Company United States Implementation and Behavioral Science, Treatment Adherence
Assessing Antiretroviral Exposure in Diverse Populations NIH National Institute of Allergy and Infectious Disease United States HIV/AIDS, Pharmacology and Drug Treatment
Developing a Mentoring Network of Diverse Mental Health Professionals Utilizing the CNICS Platform NIH National Institute of Mental Health United States Residencies, Fellowships, and Postdoctoral Training
Positive Health Access to Services and Treatment (PHAST) City and County of San Francisco United States HIV/AIDS, Implementation and Behavioral Science, Engagement in Care, Treatment Adherence
Plugging Hair ARV Levels as Adherence Biomarkers into HIV Prevention Trials NIH National Institute of Allergy and Infectious Disease Uganda HIV/AIDS
Hair measures to assess adherence and explain outcomes in an HIV clinical trial NIH National Institute of Allergy and Infectious Disease United States HIV/AIDS, Treatment Adherence
HIV Clinical Fellowship Janssen, L.P. United States HIV/AIDS, Residencies, Fellowships, and Postdoctoral Training
AIDS Clinical Trials Group Brigham and Women's Hospital United States HIV/AIDS
Intervention to reduce drug use and HIV incidence among high PrEP priority partnered YMSM Hunter College United States HIV/AIDS, Treatment Adherence
Measuring TB Drugs in Hair as a Tool to Monitor Adherence, Exposure and Response Johns Hopkins University United States Treatment Adherence
Plugging Hair ARV Levels as Adherence Biomarkers into HIV Prevention Trials NIH National Institute of Allergy and Infectious Disease Malawi; Uganda; Tanzania; Zambia; Zimbabwe; South Africa; India HIV/AIDS, Women's Health, Newborn and Infant Health, Treatment Adherence
Expanded Multidisciplinary NeuroAIDS Research Training to Improve HIV Outcomes in Nigeria Northwestern University Nigeria HIV/AIDS, Neurology and Mental Health, Dementia and Cognitive Impairment
Development of a point of care urine tenofovir immunoassay to distinguish adherence versus resistance-based HIV treatment failure Massachusetts General Hospital Uganda; South Africa HIV/AIDS, Treatment Adherence
Family Services Network - Ryan White HIV/AIDS Program U.S. Health Resources and Services Administration United States HIV/AIDS, Patient and Peer Education
Ryan White Title IV Women, Infants, Children, Youth and Affected Family Members AIDS Healthcare U.S. Health Resources and Services Administration United States HIV/AIDS
Novel Mass Spectrometry Imaging Methods to Quantify Antiretroviral Adherence University of North Carolina at Chapel Hill (UNC) United States HIV/AIDS, Treatment Adherence
Hair Extensions;: Using Hair Levels to Interpret Adherence, Effectiveness and Pharmacokinetics with Real-World Oral PrEP, the Vaginal Ring, and Injectables NIH National Institute of Allergy and Infectious Disease United States HIV/AIDS